OPGN - OpGen, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.69
-0.17 (-9.14%)
At close: 4:00PM EDT

1.55 -0.14 (-8.28%)
After hours: 7:59PM EDT

Stock chart is not supported by your current browser
Previous Close1.86
Open1.86
Bid1.55 x 1000
Ask1.79 x 2900
Day's Range1.68 - 1.85
52 Week Range1.62 - 10.25
Volume294,454
Avg. Volume92,104
Market Cap10.497M
Beta (3Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-3.60
Earnings DateNov 5, 2018 - Nov 9, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.60
Trade prices are not sourced from all markets
  • GlobeNewswire6 hours ago

    OpGen Announces Proposed Public Offering of Common Stock

    OpGen, Inc. (OPGN) today announced that it has commenced an underwritten public offering of its common stock. All of the shares are being offered by OpGen, Inc. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The Company intends to use the net proceeds of this offering for research and development, including funding the continued development and manufacturing of its Acuitas® AMR Gene Panel tests, including its Acuitas AMR Gene Panel u5.47 that was released for Research Use Only in February 2018 and its Acuitas Lighthouse® software,  to support acquisitions of products and technologies, capital expenditures, working capital and other general corporate purposes.

  • GlobeNewswire2 days ago

    OpGen Provides Business and Preliminary Financial Update

    OpGen, Inc. (OPGN) today provided an update on its commercial activities and clinical trials for its Acuitas® AMR Gene Panel tests and the Acuitas Lighthouse® Software. Preliminary unaudited results for the third quarter of 2018 were also reported. OpGen continues to make commercial progress with the Acuitas AMR Gene Panel and the Acuitas Lighthouse Software Research Use Only (RUO) products.

  • GlobeNewswire22 days ago

    OpGen to Present at Two Upcoming Investment Conferences in October

    GAITHERSBURG, Md., Sept. 25, 2018 -- OpGen, Inc. (NASDAQ: OPGN) announced today that Evan Jones, Chairman and Chief Executive Officer, will present a corporate overview at two.

  • GlobeNewswire24 days ago

    OpGen Partnering with New York State Department of Health and Merck’s ILÚM Health Solutions to Detect Antimicrobial-Resistant Infections

    OpGen, Inc. (OPGN) announced today a groundbreaking collaboration with the New York State Department of Health (“DOH”) and ILÚM Health Solutions, LLC (“ILÚM”), a wholly owned subsidiary of Merck’s Healthcare Services and Solutions, to develop a state-of-the-art research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide.

  • GlobeNewswire2 months ago

    OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

    GAITHERSBURG, Md., Aug. 29, 2018-- OpGen, Inc. announced today that Evan Jones, Chairman and Chief Executive Officer, will present a corporate overview at the 20 th Annual Rodman & Renshaw Global Investment ...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of OPGN earnings conference call or presentation 2-Aug-18 8:30pm GMT

    Q2 2018 OpGen Inc Earnings Call

  • GlobeNewswire2 months ago

    OpGen Reports Second Quarter 2018 Financial Results And Provides Business Update

    Revenue increases 12% to $0.8 million, net loss narrows 21% to $3.3 million. Conference call begins at 4:30 p.m. Eastern time today. GAITHERSBURG, Md., Aug. 02, 2018-- OpGen, Inc. today reported financial ...

  • ACCESSWIRE2 months ago

    OpGen, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 2, 2018 / OpGen, Inc. (NASDAQ: OPGN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 4:30 PM Eastern Time. To listen ...

  • Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS
    Zacks3 months ago

    Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS

    Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS

  • 5 Top-Ranked Stocks to Benefit From Rising P/E Investing
    InvestorPlace3 months ago

    5 Top-Ranked Stocks to Benefit From Rising P/E Investing

    Generally, investors love stocks with a low price-to-earnings (P/E) ratio. The idea is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not validate (is not equivalent to) its higher earnings and therefore has room to run justifies investors’ inclination toward low P/E stocks.Source: ©iStock.com/CharlieAJA

  • 5 Top-Ranked Stocks to Benefit From Rising P/E Investing
    Zacks3 months ago

    5 Top-Ranked Stocks to Benefit From Rising P/E Investing

    Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

  • GlobeNewswire3 months ago

    OpGen Announces Date of Second Quarter 2018 Financial Results Conference Call

    GAITHERSBERG, Md., July 25, 2018-- OpGen, Inc. today announced that the Company will report financial results for the three and six months ended June 30, 2018 after close of the U.S. financial markets ...

  • ACCESSWIRE3 months ago

    Free Pre-Market Technical Recap on ResMed and Three Additional Healthcare Stocks

    On Thursday, July 19, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Healthcare equities this morning: OraSure Technologies Inc. (NASDAQ: OSUR), ResMed Inc. (NYSE: RMD), OpGen Inc. (NASDAQ: OPGN), and Organovo Holdings Inc. (NASDAQ: ONVO). On Thursday, shares in Bethlehem, Pennsylvania-based OraSure Technologies Inc. recorded a trading volume of 373,287 shares.

  • ACCESSWIRE5 months ago

    Free Stock Performance Review on Organovo Holdings and Three Additional Medical Research Stocks

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on ONVO sign up now at www.wallstequities.com/registration. Durham, North Carolina headquartered IQVIA Holdings Inc.'s stock finished Wednesday's session 1.31% higher at $100.48 with a total trading volume of 968,866 shares. Over the last month and the previous three months, the Company's shares have advanced 4.93% and 2.19%, respectively.

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of OPGN earnings conference call or presentation 8-May-18 8:30pm GMT

    Q1 2018 OpGen Inc Earnings Call

  • ACCESSWIRE6 months ago

    With FDA Filing On The Horizon, NMTC Could Pull an EBIO-Like Move

    Newly public NeuroOne (NMTC) could be one of these movers in 2018 as they plan to file their first FDA medical device submission in the upcoming months. This technology addresses a large market opportunity and could support multiples of upside.